A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain

NCT05624853 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathic Pain
Diabetes Mellitus, Type 2

Interventions

DRUG: pregabalin sustained release tablet
DRUG: pregabalin immediate release capsule

Sponsor

Yuhan Corporation